GlassScriptPhysician profile
Timothy S Mologne
NPI 1881618833
$133,419.45
in general payments reported to CMS, 2019-2025
6 companies · $63K in 2025
The $63K reported for 2025 was more than what 96% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $25K · 2020: $5,523 · 2021: $519 · 2022: $972 · 2024: $38K · 2025: $63K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $97K · Travel and Lodging: $3,736 · Food and Beverage: $240.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $97,108.23 |
| Travel and Lodging | $3,736.31 |
| Food and Beverage | $240.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Joint Restoration Foundation, INC. | $129,201.63 | 2019-2025 | |
| Arthrex, INC. | $3,700.32 | 2019-2022 | |
| Great Lakes Orthopedics | $351.86 | 2019-2020 | |
| Stryker Corporation | $93.20 | 2019-2020 | |
| Fx Shoulder Solutions, INC | $44.28 | 2019 | |
| Zimmer Biomet Holdings, INC. | $28.16 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Mologne listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.